AlphaMadera's AlphaVal page classifies The Travelers Companies, Inc. as a Banks, Insurers & Asset Managers business and values it using P/Tangible Book × ROE Quality, then compares the result to the current market price to flag TRV as undervalued, fairly valued, or overvalued.

What is The Travelers Companies, Inc.'s fair value?

Fair value for TRV comes from a P/Tangible Book × ROE Quality model -- the approach AlphaVal selected for this company's Banks, Insurers & Asset Managers classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value TRV?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. TRV was classified as Banks, Insurers & Asset Managers and is valued using P/Tangible Book × ROE Quality, built from TRV's most recent reported fundamentals.

TRV - The Travelers Companies, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $351.11 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Fair Value Moderate

Trading 23.6% below fair value

Current Price $365.93

Bear Case $478.95 30.9% upside ($478.95 - $365.93) / $365.93 = 30.9% ROTCE 18.9% → 4.00x TBV

Fair Value $478.95 30.9% upside ($478.95 - $365.93) / $365.93 = 30.9% ROTCE 25.0% → 4.00x TBV

Bull Case $478.95 30.9% upside ($478.95 - $365.93) / $365.93 = 30.9% ROTCE 29.0% → 4.00x TBV

Adjust Assumptions

Return on Tangible Equity

25.2%

Cost of Equity

6.8%

Key Value Driver

ROTCE (25.2%) vs. cost of equity (6.8%)

Terminal Value % of EV

Implied Market Multiple 3.06x

Market is pricing in (growth)

Plain-Language Summary

With ROTCE of 25.2% vs. 6.8% cost of equity, fair P/TBV is 4.00x on $119.74 tangible book, implying $478.95 per share. DDM cross-check: $340.81.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (44 analysts) $351.11

Analyst Range $290.00 – $430.00

Divergence from AlphaVal 36%

Warnings

⚠ Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.

⚠ Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.

ℹ Dividend-based valuation: $340.81 (29% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.

ℹ Wall Street's average price target is $351.11 (from 44 analysts). Our estimate is 36% above the consensus -- consider that gap carefully.

Key Risks

Book value quality matters as much as level — check loan loss reserves
Interest rate sensitivity creates non-linear earnings surprises
Insurance reserving is actuarial, not financial — errors emerge slowly